SonoScape Medical's high ROE and earnings retention suggest substantial earnings growth. The decision to reinvest most profits seems to fuel this growth. The company's future, with a predicted ROE increase to 18% sans payout ratio change, seems promising.
开立医疗股票讨论区
暂无评论